Asia Pacific Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories)

Name: Asia Pacific Colorectal Cancer Market
SKU: Pharmaceuticals
Rating: 4.5 (50 reviews)

The colorectal cancer market in Asia Pacific is expected to grow from US$ 3,864.66 million in 2022 to US$ 5,169.04 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028.

The growing pharmaceutical industry in emerging economies is creating lucrative opportunities for significant players to expand their businesses in the Asia Pacific colorectal cancer market. The pharmaceutical sector in India is expected to grow from US$ 42 billion in 2021 to US$ 55 billion by 2025; it is estimated to register at a CAGR of 37% from 2021 to 2025. According to India Brand Equity Foundation (IBEF) statistics in April 2019, India is the largest provider of generic drugs worldwide. The Indian pharmaceutical industry supplies ~40% of the generic demand in the US, with ~50% of the demand for multiple vaccines and 25% of all medicines in the UK. Moreover, India has a massive number of scientists and engineers with the potential to grow the healthcare industry remarkably.

Major colorectal cancer market players focus on emerging markets such as Singapore and China as they have many colorectal cancer patients, along with growing medical tourism. As per the Australian Institute of Health and Welfare, over ~15,540 new cases of colorectal cancer were diagnosed in 2021. Moreover, as per the Malaysia Healthcare Travel Council, in 2019, over 1.22 million travelers visited Malaysia for healthcare purposes. The low cost of treatment and incorporation of advanced technologies to provide less waiting time for procedures in Asia Pacific are likely to boost the number of surgeries associated with colorectal cancer. This ultimately increases the demand for colorectal cancer diagnostics and treatment.

Thus, the increasing medical tourism and the growing pharmaceutical industry in emerging countries are expected to boost the APAC colorectal cancer market growth; it is also anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific colorectal cancer market. The Asia Pacific colorectal cancer market is expected to grow at a substantial CAGR during the forecast period.

Asia Pacific Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Asia Pacific Colorectal Cancer Market Segmentation

The Asia Pacific colorectal cancer market is segmented into modality, end user, and country. Based on modality, the Asia Pacific colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the Asia Pacific colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the Asia Pacific colorectal cancer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China held the largest market share in 2022.

Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies in the Asia Pacific colorectal cancer market.

1. Introduction 23

1.1 Scope of the Study. 23

1.2 The Insight Partners Research Report Guidance. 23

1.3 Market Segmentation. 25

1.3.1 APAC Colorectal Cancer Market – By Modality. 27

1.3.2 APAC Colorectal Cancer Market – By End User 28

1.3.3 APAC Colorectal Cancer Market – By Country. 28

2. APAC Colorectal Cancer Market – Key Takeaways 29

3. Research Methodology 32

3.1 Coverage. 34

3.2 Secondary Research. 34

3.3 Primary Research. 35

4. APAC Colorectal Cancer– Market Landscape 36

4.1 Overview.. 36

4.2 APAC PEST Analysis. 37

4.3 Expert Opinion. 38

5. APAC Colorectal Cancer Market – Key Market Dynamics 39

5.1 Market Drivers. 39

5.1.1 Increasing Prevalence of Colorectal Cancer 39

5.1.2 New Product Launches. 39

5.1.3 Benefits Offered by Generic Drugs. 40

5.2 Market Restraints. 41

5.2.1 Pricing Pressure on Drug Manufacturers. 41

5.3 Market Opportunities. 41

5.3.1 Growing Pharmaceutical Industry in Emerging Economies. 41

5.4 Future Trends. 42

5.4.1 Inclination Toward Personalized Medicine. 42

5.5 Impact Analysis. 43

6. APAC Colorectal Cancer Market– APAC Analysis 44

6.1 APAC Colorectal Cancer Market Revenue Forecast and Analysis. 44

6.1.1 Overview.. 44

7. APAC Colorectal Cancer Market Analysis – By Modality 45

7.1 Overview.. 45

7.2 APAC Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%) 45

7.3 Diagnosis Type. 46

7.3.1 Overview.. 46

7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 46

7.3.3 Immunohistochemistry. 47

7.3.3.1 Overview.. 47

7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 48

7.3.4 Stool Test 49

7.3.4.1 Overview.. 49

7.3.4.2 Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 49

7.3.5 Flexible Sigmoidoscopy. 50

7.3.5.1 Overview.. 50

7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 51

7.3.6 Colonoscopy. 52

7.3.6.1 Overview.. 52

7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 52

7.3.7 CEA Test 53

7.3.7.1 Overview.. 53

7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 54

7.3.8 Other Test 55

7.3.8.1 Overview.. 55

7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 55

7.4 Therapy Type. 56

7.4.1 Overview.. 56

7.4.2 APAC Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 57

7.4.3 Chemotherapy. 58

7.4.3.1 Overview.. 58

7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 58

7.4.3.3 Alkylating Agent 59

7.4.3.3.1 Overview.. 59

7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 60

7.4.3.4 Antimetabolites. 61

7.4.3.4.1 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 61

7.4.3.5 Others. 62

7.4.3.5.1 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 63

7.4.4 Immunotherapy. 64

7.4.4.1 Overview.. 64

7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 64

7.4.4.3 Panitumumab. 65

7.4.4.3.1 Overview.. 65

7.4.4.3.2 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 66

7.4.4.4 Cetuximab. 67

7.4.4.4.1 Overview.. 67

7.4.4.4.2 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 67

7.4.4.5 Bevacizumab. 68

7.4.4.5.1 Overview.. 68

7.4.4.5.2 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 69

7.4.4.6 Others. 70

7.4.4.6.1 Overview.. 70

7.4.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 70

7.4.5 Chemoprotectant 71

7.4.5.1 Overview.. 71

7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 72

7.4.6 Others. 73

7.4.6.1 Overview.. 73

7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 73

7.5 Imaging Type. 74

7.5.1 Overview.. 74

7.5.2 APAC Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 75

7.5.3 Computed Tomography (CT) 76

7.5.3.1 Overview.. 76

7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 76

7.5.4 Magnetic Resonance Imaging (MRI) 77

7.5.4.1 Overview.. 77

7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 78

7.5.5 Others. 79

7.5.5.1 Overview.. 79

7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 80

8. APAC Colorectal Cancer Market Revenue and Forecast To 2028 – By End User 81

8.1 Overview.. 81

8.2 APAC Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%) 81

8.3 Hospitals. 82

8.3.1 Overview.. 82

8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 82

8.4 Diagnostic and Research Laboratories. 83

8.4.1 Overview.. 83

8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 84

9. APAC Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis 85

9.1 Overview.. 85

9.1.1 APAC Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%) 87

9.1.1.1 China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million) 87

9.1.1.1.1 China Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 88

9.1.1.1.2 China: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 89

9.1.1.1.2.1 China: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 90

9.1.1.1.2.2 China: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 91

9.1.1.1.2.2.1 China: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 91

9.1.1.1.2.2.2 China: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 92

9.1.1.1.2.3 China: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 93

9.1.1.1.3 China: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 93

9.1.1.2 Japan Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 94

9.1.1.2.1 Japan Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 94

9.1.1.2.2 Japan: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 95

9.1.1.2.2.1 Japan: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 96

9.1.1.2.2.2 Japan: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 97

9.1.1.2.2.2.1 Japan: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 97

9.1.1.2.2.2.2 Japan: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 98

9.1.1.2.2.3 Japan: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 99

9.1.1.2.3 Japan : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 99

9.1.1.3 India Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 100

9.1.1.3.1 India Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 101

9.1.1.3.2 India: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 102

9.1.1.3.2.1 India: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 103

9.1.1.3.2.2 India: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 104

9.1.1.3.2.2.1 India: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 104

9.1.1.3.2.2.2 India: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 105

9.1.1.3.2.3 India: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 106

9.1.1.3.3 India : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 106

9.1.1.4 South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million) 107

9.1.1.4.1 South Korea Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 107

9.1.1.4.2 South Korea: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 108

9.1.1.4.2.1 South Korea: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 109

9.1.1.4.2.2 South Korea: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 110

9.1.1.4.2.2.1 South Korea: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 110

9.1.1.4.2.2.2 South Korea: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 111

9.1.1.4.2.3 South Korea: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 112

9.1.1.4.3 South Korea : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 112

9.1.1.5 Australia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 113

9.1.1.5.1 Australia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 113

9.1.1.5.2 Australia: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 114

9.1.1.5.2.1 Australia: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 115

9.1.1.5.2.2 Australia: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 116

9.1.1.5.2.2.1 Australia: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 117

9.1.1.5.2.2.2 Australia: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 117

9.1.1.5.2.3 Australia: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 118

9.1.1.5.3 Australia : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 119

9.1.1.6 Rest of APAC: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million) 119

9.1.1.6.1 Overview.. 119

9.1.1.6.2 Rest of APAC: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million) 120

9.1.1.6.3 Rest of APAC:: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 121

9.1.1.6.3.1 Rest of APAC: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 122

9.1.1.6.3.2 Rest of APAC: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 123

9.1.1.6.3.2.1 Rest of APAC: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 123

9.1.1.6.3.2.2 Rest of APAC: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 124

9.1.1.6.3.3 Rest of APAC: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 125

9.1.1.6.4 Rest of APAC: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 125

10. Colorectal Cancer Market – Industry Landscape 127

10.1 Overview.. 127

10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028. 128

10.3 Organic Developments. 129

10.3.1 Overview.. 129

10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028. 129

10.4 Inorganic Developments. 130

10.4.1 Overview.. 130

10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028. 131

11. Company Profiles 134

11.1 Epigenomics AG.. 134

11.1.1 Key Facts. 134

11.1.2 Business Description. 134

11.1.3 Products and Services. 135

11.1.4 Financial Overview.. 135

11.1.5 SWOT Analysis. 137

11.1.6 Key Developments. 138

11.2 Clinical Genomics Technologies Pty. Ltd. 139

11.2.1 Key Facts. 139

11.2.2 Business Description. 139

11.2.3 Products and Services. 140

11.2.4 Financial Overview.. 140

11.2.5 SWOT Analysis. 141

11.2.6 Key Developments. 142

11.3 Abbott 143

11.3.1 Key Facts. 143

11.3.2 Business Description. 143

11.3.3 Products and Services. 144

11.3.4 Financial Overview.. 146

11.3.5 SWOT Analysis. 148

11.3.6 Key Developments. 149

11.4 Amgen Inc. 150

11.4.1 Key Facts. 150

11.4.2 Business Description. 150

11.4.3 Products and Services. 151

11.4.4 Financial Overview.. 152

11.4.5 SWOT Analysis. 154

11.4.6 Key Developments. 155

11.5 F. HOFFMANN-LA ROCHE LTD. 156

11.5.1 Key Facts. 156

11.5.2 Business Description. 156

11.5.3 Products and Services. 157

11.5.4 Financial Overview.. 158

11.5.5 SWOT Analysis. 160

11.5.6 Key Developments. 161

11.6 Bruker Corporation. 162

11.6.1 Key Facts. 162

11.6.2 Business Description. 162

11.6.3 Products and Services. 163

11.6.4 Financial Overview.. 163

11.6.5 SWOT Analysis. 166

11.6.6 Key Developments. 167

11.7 Quest Diagnostics Incorporated. 168

11.7.1 Key Facts. 168

11.7.2 Business Description. 168

11.7.3 Products and Services. 169

11.7.4 Financial Overview.. 169

11.7.5 SWOT Analysis. 171

11.7.6 Key Developments. 172

11.8 EDP Biotech Corporation. 173

11.8.1 Key Facts. 173

11.8.2 Business Description. 173

11.8.3 Products and Services. 173

11.8.4 Financial Overview.. 173

11.8.5 SWOT Analysis. 174

11.8.6 Key Developments. 175

11.9 Volitionrx Limited. 176

11.9.1 Key Facts. 176

11.9.2 Business Description. 176

11.9.3 Products and Services. 177

11.9.4 Financial Overview.. 177

11.9.5 SWOT Analysis. 179

11.9.6 Key Developments. 180

12. Appendix 181

12.1 About The Insight Partners. 181

12.2 Glossary of Terms. 182

LIST OF TABLES

Table 1. China Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 89

Table 2. China Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 90

Table 3. China Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 91

Table 4. China Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 91

Table 5. China Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 92

Table 6. China Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 93

Table 7. China: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 93

Table 8. Japan Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 95

Table 9. Japan Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 96

Table 10. Japan Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 97

Table 11. Japan Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 97

Table 12. Japan Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 98

Table 13. Japan Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 99

Table 14. Japan: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 99

Table 15. India Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 102

Table 16. India Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 103

Table 17. India Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 104

Table 18. India Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 104

Table 19. India Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 105

Table 20. India Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 106

Table 21. India: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 106

Table 22. South Korea Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 108

Table 23. South Korea Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 109

Table 24. South Korea Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 110

Table 25. South Korea Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 110

Table 26. South Korea Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 111

Table 27. South Korea Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 112

Table 28. South Korea: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 112

Table 29. Australia Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 114

Table 30. Australia Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 115

Table 31. Australia Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 116

Table 32. Australia Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 117

Table 33. Australia Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 117

Table 34. Australia Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 118

Table 35. Australia: Colorectal Cancer Market Revenue and Forecast to 2028, By End Users (US$ Million) 119

Table 36. Rest of APAC: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million) 121

Table 37. Rest of APAC: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 122

Table 38. Rest of APAC: Therapy Type Market Revenue and Forecasts To 2028, By Type (US$ Million) 123

Table 39. Rest of APAC: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 123

Table 40. Rest of APAC: Colorectal Cancer Market, byImmunotherapy – Revenue and Forecast to 2028 (US$ Million) 124

Table 41. Rest of APAC: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 125

Table 42. Rest of APAC: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million) 125

Table 43. Recent Organic Growth Strategies In The Colorectal Cancer Market 129

Table 44. Recent Inorganic Growth Strategies In The Colorectal Cancer Market 131

Table 45. Glossary of Terms, APAC Colorectal Cancer Market 182

LIST OF FIGURES

Figure 1. APAC Colorectal Cancer Market Segmentation. 25

Figure 2. APAC Colorectal Cancer Segmentation, By Country. 26

Figure 3. APAC Colorectal Cancer Market Overview.. 29

Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In APAC Colorectal Cancer Market 30

Figure 5. China is Expected To Show Remarkable Growth During The Forecast Period. 31

Figure 6. APAC Colorectal Cancer Market – PEST Analysis. 37

Figure 7. Comparison of Branded Drugs and Generic Drugs. 40

Figure 8. APAC Colorectal Cancer Market Impact Analysis of Drivers And Restraints. 43

Figure 9. APAC Colorectal Cancer Market – Revenue Forecasts And Analysis – 2020- 2028. 44

Figure 10. APAC Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%) 45

Figure 11. APAC Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 47

Figure 12. APAC Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 48

Figure 13. APAC Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 50

Figure 14. APAC Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 51

Figure 15. APAC Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 53

Figure 16. APAC CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 54

Figure 17. APAC Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 56

Figure 18. APAC Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 57

Figure 19. APAC Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 59

Figure 20. APAC Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 60

Figure 21. APAC Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 62

Figure 22. APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 63

Figure 23. APAC Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 65

Figure 24. APAC Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 66

Figure 25. APAC Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 68

Figure 26. APAC Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 69

Figure 27. APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 71

Figure 28. APAC Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 72

Figure 29. APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 74

Figure 30. APAC Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 75

Figure 31. Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 77

Figure 32. APAC Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 79

Figure 33. APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 80

Figure 34. APAC Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%) 81

Figure 35. APAC Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 83

Figure 36. APAC Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 84

Figure 37. APAC: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million) 86

Figure 38. APAC Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%) 87

Figure 39. China Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 88

Figure 40. Japan Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 95

Figure 41. India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million) 101

Figure 42. South Korea Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million) 108

Figure 43. Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million) 114

Figure 44. Rest of APAC: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million) 120

Figure 45. Growth Strategies In The Colorectal Cancer Market, 2022-2028. 128

. 128

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific colorectal cancer market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the colorectal cancer market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000